Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06926608 · ClinicalTrials.gov registry record · NA
Actívatexto: Advancing Smoking Cessation and Physical Activity Among Latinos
A NA study of Smoking Cessation and Smoking, sponsored by University of Rochester.
- Recruiting
- Registry status
- NA
- Development phase
- 408
- Enrollment target
- 1
- Study location
NCT06926608: Recruiting NA study of Smoking Cessation and Smoking, sponsored by University of Rochester.
NCT06926608 is a NA study of Smoking Cessation and Smoking that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 408 participants, below the 473-participant average among 188 other Smoking Cessation trials with a reported enrollment target (14% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06926608, a NA study of Smoking Cessation and Smoking, is actively recruiting participants, sponsored by University of Rochester.
- RECRUITING
- Registry status
- NA
- Development phase
- 408 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this randomized controlled trial is to assess the efficacy of Actívatexto (Aim 1) and the mediators of the presumed treatment effect (Aim 2) among Latino adults who smoke. Actívatexto is a mobile intervention that integrates four components: 1) a text messaging program that promotes both smoking cessation and physical activity, 2) wearable devices to monitor physical activity, 3) smoking cessation pharmacotherapy \[i.e., nicotine replacement therapies (NRT)\], and 4) an online dashboard where the research team manages participants' incoming and outgoing data from both the text messaging program and wearable devices.
Primary Outcome
Cotinine levels ≤15 ng/mL in saliva
Conditions Studied
Interventions
- BEHAVIORAL Actívatexto
- BEHAVIORAL Decídetexto
Study Locations (1)
New York
- University of Rochester Medical Center - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 408 participants |
| Start Date | 2025-06-17 |
| Est. Completion | 2029-05-31 |
| Phase | NA |
What NCT06926608 shows while recruiting
NCT06926608 is an interventional study that assigns participants to a tested intervention. The registered 408 participants enrollment target is mid-sized for trials with a published cap, below the 473-participant average among 188 other Smoking Cessation trials with a reported enrollment target (14% lower).
The record links to 3 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which Actívatexto is the first listed.
NCT06926608 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06926608 about?
NCT06926608 is a clinical study titled "Actívatexto: Advancing Smoking Cessation and Physical Activity Among Latinos". The purpose of this randomized controlled trial is to assess the efficacy of Actívatexto (Aim 1) and the mediators of the presumed treatment effect (Aim 2) among Latino adults who smoke. Actívatexto is a mobile intervention that integrates four components: 1) a text messaging program that promotes b...
What is the current status of trial NCT06926608?
This trial is currently recruiting. It is a NA study. The enrollment target is 408 participants. The study started on 2025-06-17. Estimated completion is 2029-05-31.
What conditions does trial NCT06926608 study?
This clinical trial studies the following conditions: Smoking Cessation, Smoking, Physical Inactivity.
What interventions are being tested in trial NCT06926608?
The interventions under investigation include: Actívatexto (BEHAVIORAL), Decídetexto (BEHAVIORAL).
Who is sponsoring clinical trial NCT06926608?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06926608 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06926608's enrollment target sits among peer trials
408 66th of 188 higher than 122 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04835428 · 408 participants · NA
STAND - Study of the AGN1 LOEP SV Kit Compared to PMMA in Patients With Vertebral Compression Fractures
- NCT05836324 · 408 participants · Phase 1
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
- NCT05863195 · 408 participants · Phase 3
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
- NCT06612268 · 408 participants · Phase 3
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI